DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Q2 Results Today Live: BSE, Cummins, Zydus Lifesciences, Apollo, Lenskart, Nykaa, Aurobindo Pharma, NHPC, Dabur, Torrent Power, Biocon, Sundaram Finance, Premier Energies, Physicswallah Share to announce Q2 results, Bajaj Finserv, SBI, NSE, Lupin shares in focus

BusinessLine 1 hr ago·4 Nov 2026, 3:43 am

Zydus Lifesciences is set to announce its financial results for the second quarter of the fiscal year. Investors will closely watch the company's performance to gauge its growth trajectory amidst a competitive pharmaceutical landscape.

These quarterly results are crucial for understanding Zydus's operational efficiency and market expansion strategies. Strong earnings could signal robust demand for its drug portfolio, while any misses might raise concerns about profitability and future growth.

Market participants will be particularly interested in the management's commentary on the outlook for the remaining quarters and any updates on key product launches or pipeline developments.